Weight loss follows a relatively smooth curve with gradual deceleration after the first six months
Theyve made such a splash that the journal Science named GLP-1 drugs the 2023 Breakthrough of the Year
Cagrilintide is an amylin receptor agonist , a synthetic version of a hormone your pancreas already produces every time you eat
Boora added, "Weight regain can happen, but how much partly depends on the habits people have built while on the medication." Sainikhil Sontha, a research associate at Boston University School of Public Health, warned in a statement, "Stopping [treatment] early may mean missed opportunities to prevent heart attacks, kidney disease progression and other complications." Why People Stop Taking GLP-1 Drugs The study also highlighted several factors linked to why people discontinue treatment
Wegovy Important Safety Information: Read more about serious warnings and safety info
How does it actually reduce body weight